210 related articles for article (PubMed ID: 22136947)
21. Comparison of the prognosis of bisphosphonate-related osteonecrosis of the jaw caused by oral and intravenous bisphosphonates.
Shintani T; Hayashido Y; Mukasa H; Akagi E; Hoshino M; Ishida Y; Hamana T; Okamoto K; Kanda T; Koizumi K; Yoshioka Y; Tani R; Toratani S; Okamoto T
Int J Oral Maxillofac Surg; 2015 Jul; 44(7):840-4. PubMed ID: 25861974
[TBL] [Abstract][Full Text] [Related]
22. Resolution of oral bisphosphonate and steroid-related osteonecrosis of the jaw--a serial case analysis.
Chiu CT; Chiang WF; Chuang CY; Chang SW
J Oral Maxillofac Surg; 2010 May; 68(5):1055-63. PubMed ID: 20403529
[TBL] [Abstract][Full Text] [Related]
23. A retrospective study evaluating frequency and risk factors of osteonecrosis of the jaw in 576 cancer patients receiving intravenous bisphosphonates.
Thumbigere-Math V; Tu L; Huckabay S; Dudek AZ; Lunos S; Basi DL; Hughes PJ; Leach JW; Swenson KK; Gopalakrishnan R
Am J Clin Oncol; 2012 Aug; 35(4):386-92. PubMed ID: 22561331
[TBL] [Abstract][Full Text] [Related]
24. Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.
Assaf AT; Smeets R; Riecke B; Weise E; Gröbe A; Blessmann M; Steiner T; Wikner J; Friedrich RE; Heiland M; Hoelzle F; Gerhards F
Anticancer Res; 2013 Sep; 33(9):3917-24. PubMed ID: 24023329
[TBL] [Abstract][Full Text] [Related]
25. Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients.
Thumbigere-Math V; Sabino MC; Gopalakrishnan R; Huckabay S; Dudek AZ; Basu S; Hughes PJ; Michalowicz BS; Leach JW; Swenson KK; Swift JQ; Adkinson C; Basi DL
J Oral Maxillofac Surg; 2009 Sep; 67(9):1904-13. PubMed ID: 19686928
[TBL] [Abstract][Full Text] [Related]
26. [Bisphosphonate-related osteonecrosis of the jaw].
Franken AA; van Blijderveen NJ; Witjes MJ; Netelenbos CJ
Ned Tijdschr Geneeskd; 2011; 155():A3077. PubMed ID: 21486510
[TBL] [Abstract][Full Text] [Related]
27. Quantification by energy dispersive x-ray spectroscopy of alendronate in the diseased jaw bone of patients with bisphosphonate-related jaw osteonecrosis.
Schaudinn C; Gorur A; Webster P; Jones AC; Neely M; Jelliffe RW; Le AD; Sedghizadeh PP
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Oct; 114(4):480-6. PubMed ID: 22986243
[TBL] [Abstract][Full Text] [Related]
28. A study of 225 patients on bisphosphonates presenting to the bisphosphonate clinic at King's College Hospital.
Taylor T; Bryant C; Popat S
Br Dent J; 2013 Apr; 214(7):E18. PubMed ID: 23579162
[TBL] [Abstract][Full Text] [Related]
29. Bisphosphonate-related osteonecrosis of the jaw.
Feller L; Wood NH; Khammissa RA; Chikte UM; Bouckaert M; Lemmer J
SADJ; 2011 Feb; 66(1):30-2. PubMed ID: 21510174
[TBL] [Abstract][Full Text] [Related]
30. Dental extraction as a risk factor for bisphosphonate related osteonecrosis of the jaw in cancer patients: an update.
Utreja A; Almas K; Javed F
Odontostomatol Trop; 2013 Jun; 36(142):38-46. PubMed ID: 24073539
[TBL] [Abstract][Full Text] [Related]
31. Dental implications of bisphophonate-related osteonecrosis.
Saldanha S; Shenoy VK; Eachampati P; Uppal N
Gerodontology; 2012 Sep; 29(3):177-87. PubMed ID: 22486711
[TBL] [Abstract][Full Text] [Related]
32. [A case of bisphosphonate-related osteonecrosis of the jaw in a patient who had received intravenous bisphosphonates].
Ishikawa T
Gan To Kagaku Ryoho; 2014 Feb; 41(2):225-7. PubMed ID: 24743202
[TBL] [Abstract][Full Text] [Related]
33. [Clinical investigation of bisphosphonate-related osteonecrosis of the jaws].
Dehari H; Tomihara K; Ueda M; Shimanishi M; Ono M; Sasaki T; Igarashi T; Shiratori K; Abe M; Ogi K; Nakamori K; Miyazaki A; Nagai I; Hiratsuka H
Gan To Kagaku Ryoho; 2009 Dec; 36(13):2587-92. PubMed ID: 20009460
[TBL] [Abstract][Full Text] [Related]
34. Bisphosphonate-related osteonecrosis of the jaws: a case series of 25 patients affected by osteoporosis.
Manfredi M; Merigo E; Guidotti R; Meleti M; Vescovi P
Int J Oral Maxillofac Surg; 2011 Mar; 40(3):277-84. PubMed ID: 21163625
[TBL] [Abstract][Full Text] [Related]
35. Observation of pain control in patients with bisphosphonate-induced osteonecrosis using low level laser therapy: preliminary results.
Romeo U; Galanakis A; Marias C; Vecchio AD; Tenore G; Palaia G; Vescovi P; Polimeni A
Photomed Laser Surg; 2011 Jul; 29(7):447-52. PubMed ID: 21235406
[TBL] [Abstract][Full Text] [Related]
36. Bisphosphonate-related osteonecrosis of the jaw: from the sine qua non condition of bone exposure to a non-exposed BRONJ entity.
Koth VS; Figueiredo MA; Salum FG; Cherubini K
Dentomaxillofac Radiol; 2016; 45(7):20160049. PubMed ID: 27167455
[TBL] [Abstract][Full Text] [Related]
37. A Strategy against the Osteonecrosis of the Jaw Associated with Nitrogen-Containing Bisphosphonates (N-BPs): Attempts to Replace N-BPs with the Non-N-BP Etidronate.
Oizumi T; Yamaguchi K; Sato K; Takahashi M; Yoshimura G; Otsuru H; Tsuchiya M; Hagiwara Y; Itoi E; Sugawara S; Takahashi T; Endo Y
Biol Pharm Bull; 2016; 39(9):1549-54. PubMed ID: 27582334
[TBL] [Abstract][Full Text] [Related]
38. Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A critical review.
Vescovi P; Nammour S
Minerva Stomatol; 2010 Apr; 59(4):181-203, 204-13. PubMed ID: 20360666
[TBL] [Abstract][Full Text] [Related]
39. Prospective biomarker evaluation in patients with osteonecrosis of the jaw who received bisphosphonates.
Kim JW; Kong KA; Kim SJ; Choi SK; Cha IH; Kim MR
Bone; 2013 Nov; 57(1):201-5. PubMed ID: 23954759
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of the early stages of intravenous bisphosphonate-related osteonecrosis of the jaw in patients with breast cancer.
Matsuo A; Hamada H; Kaise H; Chikazu D; Yamada K; Kohno N
Acta Odontol Scand; 2014 Nov; 72(8):656-63. PubMed ID: 24521290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]